Towards consensus practices to qualify safety biomarkers for use in early drug development : The predictive safety testing consortium

Saved in:
Bibliographic Details
Published inNature biotechnology Vol. 28; no. 5; pp. 446 - 454
Main Authors SISTARE, Frank D, DIETERLE, Frank, COLLINS, Nathaniel, GOERING, Peter, GOODSAID, Federico, GU, Yi-Zhong, GUILPIN, Valerie, HARPUR, Ernie, HASSAN, Alita, JACOBSON-KRAM, David, KASPER, Peter, LAURIE, David, TROTH, Sean, SILVA LIMA, Beatriz, MACIULAITIS, Romaldas, MATTES, William, MAURER, Gérard, OBERT, Leslie Ann, OZER, Josef, PAPALUCA-AMATI, Marisa, PHILLIPS, Jonathan A, PINCHES, Mark, SCHIPPER, Matthew J, HOLDER, Daniel J, THOMPSON, Karol L, VAMVAKAS, Spiros, VIDAL, Jean-Marc, VONDERSCHER, Jacky, WALKER, Elizabeth, WEBB, Craig, YAN YU, GERHOLD, David, ANDREWS-CLEAVENGER, Dina, BAER, William, BETTON, Graham, BOUNOUS, Denise, CARL, Kevin
Format Journal Article
LanguageEnglish
Published New York, NY Nature Publishing Group 2010
Subjects
Biological and medical sciences
Drug toxicity and drugs side effects treatment
Medical sciences
Pharmacology. Drug treatments
Toxicity: urogenital system
Drug
Qualification
Decision making
Toxicity
Biological marker
Safety
Nephrotoxicity
Research and development
Online AccessGet full text

Cover

More Information
ISSN:1087-0156
1546-1696